TAKEDA PHARMA - Dusseldorf Stock Exchang
TAKEDA PHARMA - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
Market Cap & Net Worth: TAKEDA PHARMA - Dusseldorf Stock Exchang (TKD)
TAKEDA PHARMA - Dusseldorf Stock Exchang (DU:TKD) has a market capitalization of $301.28K (€293.51K) as of March 19, 2026. Listed on the DU stock exchange, this Germany-based company holds position #38553 globally and #5266 in its home market, demonstrating a -0.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TAKEDA PHARMA - Dusseldorf Stock Exchang's stock price €30.46 by its total outstanding shares 9636 (9.64K).
TAKEDA PHARMA - Dusseldorf Stock Exchang Market Cap History: 2015 to 2026
TAKEDA PHARMA - Dusseldorf Stock Exchang's market capitalization history from 2015 to 2026. Data shows change from $454.69K to $301.28K (-2.95% CAGR).
TAKEDA PHARMA - Dusseldorf Stock Exchang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TAKEDA PHARMA - Dusseldorf Stock Exchang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
TAKEDA PHARMA - Dusseldorf Stock Exchang's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
TAKEDA PHARMA - Dusseldorf Stock Exchang's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $464.04K | $1.73 Trillion | $114.94 Billion | 0.00x | 0.00x |
| 2018 | $286.35K | $1.77 Trillion | $186.89 Billion | 0.00x | 0.00x |
| 2019 | $346.53K | $2.10 Trillion | $109.13 Billion | 0.00x | 0.00x |
| 2020 | $291.69K | $3.29 Trillion | $44.24 Billion | 0.00x | 0.00x |
| 2021 | $237.39K | $3.20 Trillion | $376.00 Billion | 0.00x | 0.00x |
| 2022 | $283.08K | $3.57 Trillion | $230.06 Billion | 0.00x | 0.00x |
| 2023 | $253.90K | $4.03 Trillion | $317.02 Billion | 0.00x | 0.00x |
| 2024 | $247.48K | $4.26 Trillion | $144.07 Billion | 0.00x | 0.00x |
Competitor Companies of TKD by Market Capitalization
Companies near TAKEDA PHARMA - Dusseldorf Stock Exchang in the global market cap rankings as of March 19, 2026.
Key companies related to TAKEDA PHARMA - Dusseldorf Stock Exchang by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
TAKEDA PHARMA - Dusseldorf Stock Exchang Historical Marketcap From 2015 to 2026
Between 2015 and today, TAKEDA PHARMA - Dusseldorf Stock Exchang's market cap moved from $454.69K to $ 301.28K, with a yearly change of -2.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €301.28K | +17.52% |
| 2025 | €256.38K | +3.60% |
| 2024 | €247.48K | -2.53% |
| 2023 | €253.90K | -10.31% |
| 2022 | €283.08K | +19.25% |
| 2021 | €237.39K | -18.62% |
| 2020 | €291.69K | -15.83% |
| 2019 | €346.53K | +21.02% |
| 2018 | €286.35K | -38.29% |
| 2017 | €464.04K | +21.13% |
| 2016 | €383.08K | -15.75% |
| 2015 | €454.69K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of TAKEDA PHARMA - Dusseldorf Stock Exchang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $301.28K USD |
| MoneyControl | $301.28K USD |
| MarketWatch | $301.28K USD |
| marketcap.company | $301.28K USD |
| Reuters | $301.28K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.